Notch signaling in CD66+ cells drives the progression of human cervical cancers.
about
The notch ligand JAGGED1 as a target for anti-tumor therapyFrom fly wings to targeted cancer therapies: a centennial for notch signalingInhibition of Notch signaling alters the phenotype of orthotopic tumors formed from glioblastoma multiforme neurosphere cells but does not hamper intracranial tumor growth regardless of endogene Notch pathway signatureBiological significance and therapeutic implication of resveratrol-inhibited Wnt, Notch and STAT3 signaling in cervical cancer cellsCD66+ cells in cervical precancers are partially differentiated progenitors with neoplastic traitsPromoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.Notch-1 signaling promotes the malignant features of human breast cancer through NF-κB activationHuman papillomavirus 16E6 and NFX1-123 potentiate Notch signaling and differentiation without activating cellular arrestSquamous Cell Cancers: A Unified Perspective on Biology and GeneticsNFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes.Roles of CEACAM1 in cell communication and signaling of lung cancer and other diseases.Notch-1 signaling activates NF-κB in human breast carcinoma MDA-MB-231 cells via PP2A-dependent AKT pathway.Live detection and purification of cells based on the expression of a histone chaperone, HIRA, using a binding peptide.TM1-IR680 peptide for assessment of surgical margin and lymph node metastasis in murine orthotopic model of oral cancerCrosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.Cervical Cancer Cell Growth, Drug Resistance, and Epithelial-Mesenchymal Transition Are Suppressed by g-Secretase Inhibitor RO4929097.
P2860
Q21129294-2DBDF0C0-D1A7-49D9-95E7-BC2212CD0510Q27004534-04B8BC0C-72DA-4F02-A121-458F47142533Q33911184-489BFB62-A457-47A1-B1B0-645AE35B4D15Q33925336-C1D53D3E-F9D1-4DB8-91CD-C78F225CA129Q34518394-A349627D-7DA4-46F4-858F-64FA32B764E7Q35097588-78023D6D-2D50-44A2-8145-96E00FA36F57Q35156280-E156B417-67ED-4A11-AAAA-3448F07C6EFCQ35248947-CD2F21BF-DC84-49C4-B1CC-56B2C2011915Q36909843-9A0CDE36-132C-481F-A479-B1905E1CB987Q37336719-4645E2FE-9A79-49B3-B4D4-1CDDD2D10F35Q38529754-7AA39572-3483-4BD3-A2F6-66F23279F997Q38788709-4F93B0DC-BCF6-4227-A34D-5D4C2C922EBEQ40286979-B09C411C-F3FA-4B95-84CA-294A250271BDQ42142709-B8447BEB-3B36-4002-B1F6-838540F170EEQ49913258-C0BCBE5B-16BE-4876-A649-59FFCA93D639Q55519614-E09424AF-5046-402C-8D91-567A5C36F0C3
P2860
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@en
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@nl
type
label
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@en
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@nl
prefLabel
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@en
Notch signaling in CD66+ cells drives the progression of human cervical cancers.
@nl
P2093
P1433
P1476
Notch signaling in CD66+ cells drives the progression of human cervical cancers
@en
P2093
Deepa Subramanyam
Eric Vivien
H Krishnamurthy
Jeevisha Bajaj
Sudhir Krishna
Tessy Thomas Maliekal
P304
P356
10.1158/0008-5472.CAN-11-0543
P407
P577
2011-06-06T00:00:00Z